Description
GLP-1 / GIP / GLUCAGON 10mg (x10 vials) – Research-Grade Triple Receptor Peptide
Delivery Time: 1–2 Weeks for 10 Packs
GLP-1 / GIP / GLUCAGON 10mg is a high-purity, research-grade peptide formulated exclusively for laboratory and analytical research applications. GLP-1 / GIP / GLUCAGON is a triple receptor peptide that interacts with GLP-1, GIP, and glucagon receptor pathways, and is referenced in scientific literature for cellular signaling, receptor binding, and pathway modulation in receptor signalling research models.
This product is strictly for laboratory research purposes only and is not approved for human or veterinary use, clinical use, or therapeutic application.
What Is GLP-1 / GIP / GLUCAGON?
GLP-1 / GIP / GLUCAGON is a synthetic triple receptor peptide designed for research into GLP-1, GIP, and glucagon receptor signaling. In controlled laboratory studies, it is referenced for experiments involving:
• Receptor-binding and intracellular signaling pathways
• Multi-receptor pathway analysis
• Receptor signalling in in vitro and ex vivo models
• Analytical and mechanistic research on receptor interactions
All uses are limited to research environments; this product is not intended for consumption or therapeutic purposes.
Research Applications of GLP-1 / GIP / GLUCAGON 10mg
GLP-1 / GIP / GLUCAGON 10mg is suitable for laboratory studies focusing on:
• GLP-1, GIP, and Glucagon Receptor Research – Investigating receptor interactions and signaling mechanisms
• Receptor signalling Pathway Analysis – Studying intracellular pathways in controlled laboratory models
• Multi-Receptor Investigations – Exploring interactions across GLP-1, GIP, and glucagon receptors
• Analytical and Biochemical Research – For receptor characterization, dose-response testing, and pathway exploration
• Extended Laboratory Protocols – Appropriate for multi-dose or batch studies requiring consistent peptide supply
All applications are strictly for laboratory research, with no human or veterinary use.
Product Specifications
• Peptide: GLP-1 / GIP / GLUCAGON
• Concentration: 10mg per vial × 10 vials
• Grade: Research-Grade
• Intended Use: Laboratory research only
• Storage: Follow standard peptide storage and laboratory handling protocols
The 10-vial pack provides flexibility for multi-phase experiments and repeated testing protocols.
Purity & Quality Assurance
ExoLabz peptides undergo rigorous third-party testing to confirm identity, purity, and consistency. Each GLP-1 / GIP / GLUCAGON 10mg batch is verified by COA.
Independent testing is encouraged. If verified results do not meet stated specifications, ExoLabz provides a refund and testing reimbursement, ensuring full confidence in research integrity.
Important Legal Disclaimer
For Research Purposes Only
GLP-1 / GIP / GLUCAGON 10mg is intended strictly for laboratory research and scientific investigation. It is not approved by Health Canada, FDA, or any other regulatory authority. This product is not for human consumption, clinical use, or therapeutic application. By purchasing, you agree to use it exclusively for lawful research purposes.
Research Literature
Peer-reviewed studies involving this compound and its class. All findings listed are from in vitro, cell culture or animal models and are provided for scientific reference only. This product is supplied for laboratory research and is not approved for human consumption, clinical, or veterinary use.
- Willard FS, et al. JCI Insight. 2020;5(17):e140532. In HEK293 and CHO-K1 cells, measured competition radioligand binding, cAMP accumulation, beta-arrestin recruitment and receptor internalisation at human GIPR and GLP-1R. Source · PMID 32730231
- Zhao F, et al. Nat Commun. 2022;13:1057. Solved five cryo-EM structures of Gs-coupled GIPR, GLP-1R and GCGR at 3.0-3.5 A and measured cAMP potency across site-directed receptor mutants. Source · PMID 35217653
- Knerr PJ, et al. Mol Metab. 2022;63:101533. Rodent study comparing triagonists with tuned GLP-1R/GIPR/GCGR potency ratios; see the linked record for methods and endpoints. Source · PMID 35809773
Literature notes: References concern receptor pharmacology and preclinical models. Clinical literature is outside the scope of this list.
Related Research Compounds
Browse more compounds in Incretin & Glucagon Peptides, or view the full research peptide catalogue.
